Compartment-resolved Proteomic Analysis of Mouse Aorta during Atherosclerotic Plaque Formation Reveals Osteoclast-specific Protein Expression

Molecular and Cellular Proteomics

Volumn 17, Issue 2, 2018, Pages 321-334

  Wierer, Michael ^a,f   Prestel, Matthias ^b,g   Schiller, Herbert B ^a,c,f,g   Yan, Guangyao ^b,g   Schaab, Christoph ^a,f   Azghandi, Sepiede ^b,g   Werner, Julia ^d   Kessler, Thorsten ^d   Malik, Rainer ^b,g   Murgia, Marta ^a,b,e,f   Aherrahrou, Zouhair ^a,b,f,g   Schunkert, Heribert ^c,g   Dichgans, Martin ^b,g   Mann, Matthias ^a,f  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY OF LÜBECK   (Germany)

^g DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; DETERGENT; MAM DOMAIN CONTAINING 2 PROTEIN; MATRILIN; MATRILIN 2; MATRIX METALLOPROTEINASE; PEROXIDASIN; PROTEIN; PROTEOME; UNCLASSIFIED DRUG; SCLEROPROTEIN;

ANIMAL EXPERIMENT; APOLIPOPROTEIN E KNOCKOUT MOUSE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; COMPARTMENT MODEL; CONTROLLED STUDY; CROSS LINKING; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; LIPID DIET; MACROPHAGE FUNCTION; MASS SPECTROMETRY; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; ANIMAL; AORTA; C57BL MOUSE; FEMALE; MALE; METABOLISM;

ANIMALS; AORTA; EXTRACELLULAR MATRIX PROTEINS; FEMALE; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT, APOE; OSTEOCLASTS; PLAQUE, ATHEROSCLEROTIC; PROTEOME;

EID: 85041719074     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.RA117.000315     Document Type: Article

References (85)

1. WHO. Cardiovascular diseases (CVDs). 2017; Available from: http://www.who.int/mediacentre/factsheets/fs317/en/.
2. Kannel, W. B., Wolf, P. A., and Verter, J. (1983) Manifestations of coronary disease predisposing to stroke. The Framingham study. JAMA 250, 2942–2946
3. Iso, H., Jacobs, D. R., Jr., Wentworth, D., Neaton, J. D., and Cohen, J. D. (1989) Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N. Engl. J. Med. 320, 904–910
4. Sacco, R. L., Benjamin, E. J., Broderick, J. P., Dyken, M., Easton, J. D., Feinberg, W. M., Goldstein, L. B., Gorelick, P. B., Howard, G., Kittner, S. J., Manolio, T. A., Whisnant, J. P., and Wolf, P. A. (1997) American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke 28, 1507–1517
5. Dichgans, M., Malik, R., Konig, I. R., Rosand, J., Clarke, R., Gretarsdottir, S., Thorleifsson, G., Mitchell, B. D., Assimes, T. L., Levi, C., O’Donnell, C. J., Fornage, M., Thorsteinsdottir, U., Psaty, B. M., Hengstenberg, C., Seshadri, S., Erdmann, J., Bis, J. C., Peters, A., Boncoraglio, G. B., Marz, W., Meschia, J. F., Kathiresan, S., Ikram, M. A., McPherson, R., Stefansson, K., Sudlow, C., Reilly, M. P., Thompson, J. R., Sharma, P., Hopewell, J. C., Chambers, J. C., Watkins, H., Rothwell, P. M., Roberts, R., Markus, H. S., Samani, N. J., Farrall, M., and Schunkert, H. (2014) Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke 45, 24–36
6. Hansson, G. K. (2005) Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685–1695
7. Hansson, G. K., and Hermansson, A. (2011) The immune system in atherosclerosis. Nat. Immunol. 12, 204–212
8. Weber, C., Zernecke, A., and Libby, P. (2008) The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat. Rev. Immunol. 8, 802–815
9. Weber, C., and Noels, H. (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17, 1410–1422
10. Hansson, G. K., and Libby, P. (2006) The immune response in atherosclerosis: a double-edged sword. Nat. Rev. Immunol. 6, 508–519
11. Woollard, K. J., and Geissmann, F. (2010) Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 7, 77–86
12. Libby, P. (2001) Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104, 365–372
13. Dobrin, P. B. (1978) Mechanical properties of arterises. Physiol. Rev. 58, 397–460
14. Siow, R. C., and Churchman, A. T. (2007) Adventitial growth factor signal-ling and vascular remodelling: potential of perivascular gene transfer from the outside-in. Cardiovasc. Res. 75, 659–668
15. Wagenseil, J. E., and Mecham, R. P. (2009) Vascular extracellular matrix and arterial mechanics. Physiol. Rev. 89, 957–989
16. Libby, P., and Hansson, G. K. (2015) Inflammation and immunity in diseases of the arterial tree: players and layers. Circ. Res. 116, 307–311
17. Amento, E. P., Ehsani, N., Palmer, H., and Libby, P. (1991) Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler. Thromb. 11, 1223–1230
18. Hahn, C., and Schwartz, M. A. (2009) Mechanotransduction in vascular physiology and atherogenesis. Nat. Rev. Mol. Cell Biol. 10, 53–62
19. Hynes, R. O. (2009) The extracellular matrix: not just pretty fibrils. Science 326, 1216–1219
20. Schwartz, M. A. (2010) Integrins and extracellular matrix in mechanotrans-duction. Cold Spring Harb. Perspect. Biol. 2:a005066
21. Hynes, R. O. (2012) The evolution of metazoan extracellular matrix. J. Cell Biol. 196, 671–679
22. Chistiakov, D. A., Sobenin, I. A., and Orekhov, A. N. (2013) Vascular extracellular matrix in atherosclerosis. Cardiol. Rev. 21, 270–288
23. Bonnans, C., Chou, J., and Werb, Z. (2014) Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15, 786–801
24. Naba, A., Clauser, K. R., Ding, H., Whittaker, C. A., Carr, S. A., and Hynes, R. O. (2016) The extracellular matrix: Tools and insights for the “omics” era. Matrix Biol. 49, 10–24
25. Naba, A., Hoersch, S., and Hynes, R. O. (2012) Towards definition of an ECM parts list: an advance on GO categories. Matrix Biol. 31, 371–372
26. Naba, A., Clauser, K. R., Hoersch, S., Liu, H., Carr, S. A., and Hynes, R. O. (2012) The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell. Proteomics 11, M111.014647
27. Cromar, G. L., Xiong, X., Chautard, E., Ricard-Blum, S., and Parkinson, J. (2012) Toward a systems level view of the ECM and related proteins: a framework for the systematic definition and analysis of biological systems. Proteins 80, 1522–1544
28. Frantz, C., Stewart, K. M., and Weaver, V. M. (2010) The extracellular matrix at a glance. J. Cell Sci. 123, 4195– 4200
29. Hynes, R. O., and Naba, A. (2012) Overview of the matrisome–an inventory of extracellular matrix constituents and functions. Cold Spring Harb. Perspect. Biol. 4:a004903
30. Mayr, M., Chung, Y. L., Mayr, U., Yin, X., Ly, L., Troy, H., Fredericks, S., Hu, Y., Griffiths, J. R., and Xu, Q. (2005) Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler. Thromb. Vasc. Biol. 25, 2135–2142
31. de la Cuesta, F., Barderas, M. G., Calvo, E., Zubiri, I., Maroto, A. S., Darde, V. M., Martin-Rojas, T., Gil-Dones, F., Posada-Ayala, M., Tejerina, T., Lopez, J. A., Vivanco, F., and Alvarez-Llamas, G. (2012) Secretome analysis of atherosclerotic and non-atherosclerotic arteries reveals dynamic extracellular remodeling during pathogenesis. J. Proteomics 75, 2960–2971
32. Bagnato, C., Thumar, J., Mayya, V., Hwang, S. I., Zebroski, H., Claffey, K. P., Haudenschild, C., Eng, J. K., Lundgren, D. H., and Han, D. K. (2007) Proteomics analysis of human coronary atherosclerotic plaque: a feasibility study of direct tissue proteomics by liquid chromatography and tandem mass spectrometry. Mol. Cell. Proteomics 6, 1088–1102
33. Lynch, M., Barallobre-Barreiro, J., Jahangiri, M., and Mayr, M. (2016) Vascular proteomics in metabolic and cardiovascular diseases. J. Intern. Med. 280, 325–338
34. Lennon, R., Byron, A., Humphries, J. D., Randles, M. J., Carisey, A., Murphy, S., Knight, D., Brenchley, P. E., Zent, R., and Humphries, M. J. (2014) Global analysis reveals the complexity of the human glomerular extracellular matrix. J. Am. Soc. Nephrol. 25, 939–951
35. Randles, M. J., Woolf, A. S., Huang, J. L., Byron, A., Humphries, J. D., Price, K. L., Kolatsi-Joannou, M., Collinson, S., Denny, T., Knight, D., Mironov, A., Starborg, T., Korstanje, R., Humphries, M. J., Long, D. A., and Lennon, R. (2015) Genetic background is a key determinant of glomerular extracellular matrix composition and organization. J. Am. Soc. Nephrol. 26, 3021–3034
36. Didangelos, A., Yin, X., Mandal, K., Baumert, M., Jahangiri, M., and Mayr, M. (2010) Proteomics characterization of extracellular space components in the human aorta. Mol. Cell. Proteomics 9, 2048–2062
37. Langley, S. R., Willeit, K., Didangelos, A., Matic, L. P., Skroblin, P., Baral-lobre-Barreiro, J., Lengquist, M., Rungger, G., Kapustin, A., Kedenko, L., Molenaar, C., Lu, R., Barwari, T., Suna, G., Yin, X., Iglseder, B., Paulweber, B., Willeit, P., Shalhoub, J., Pasterkamp, G., Davies, A. H., Monaco, C., Hedin, U., Shanahan, C. M., Willeit, J., Kiechl, S., and Mayr, M. (2017) Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques. J. Clin. Invest. 127, 1546–1560
38. Aebersold, R., and Mann, M. (2016) Mass-spectrometric exploration of proteome structure and function. Nature 537, 347–355
39. Schiller, H. B., Fernandez, I. E., Burgstaller, G., Schaab, C., Scheltema, R. A., Schwarzmayr, T., Strom, T. M., Eickelberg, O., and Mann, M. (2015) Time- and compartment-resolved proteome profiling of the extracellular niche in lung injury and repair. Mol. Syst. Biol. 11, 819
40. Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., and Maeda, N. (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 89, 4471–4475
41. Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setala, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., and Breslow, J. L. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353
42. Kulak, N. A., Pichler, G., Paron, I., Nagaraj, N., and Mann, M. (2014) Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells. Nat. Methods 11, 319–324
43. Cox, J., and Mann, M. (2008) MaxQuant enables high peptide identification rates, individualized p. p. b.-range mass accuracies and proteome-wide protein quantification. Nature Biotechnol. 26, 1367–1372
44. Tyanova, S., Temu, T., Sinitcyn, P., Carlson, A., Hein, M. Y., Geiger, T., Mann, M., and Cox, J. (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740
45. Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., Gordonov, S., Mazloom, A. R., Ma’ayan, A., Chua, W. J., Hansen, T. H., Turley, S. J., Merad, M., and Randolph, G. J. (2012) Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13, 1118 –1128
46. Jojic, V., Shay, T., Sylvia, K., Zuk, O., Sun, X., Kang, J., Regev, A., Koller, D., Immunological Genome Project, C., Best, A. J., Knell, J., Goldrath, A., Joic, V., Koller, D., Shay, T., Regev, A., Cohen, N., Brennan, P., Brenner, M., Kim, F., Rao, T. N., Wagers, A., Heng, T., Ericson, J., Rothamel, K., Ortiz-Lopez, A., Mathis, D., Benoist, C., Bezman, N. A., Sun, J. C., Min-Oo, G., Kim, C. C., Lanier, L. L., Miller, J., Brown, B., Merad, M., Gautier, E. L., Jakubzick, C., Randolph, G. J., Monach, P., Blair, D. A., Dustin, M. L., Shinton, S. A., Hardy, R. R., Laidlaw, D., Collins, J., Gazit, R., Rossi, D. J., Malhotra, N., Sylvia, K., Kang, J., Kreslavsky, T., Fletcher, A., Elpek, K., Bellemarte-Pelletier, A., Malhotra, D., and Turley, S. (2013) Identification of transcriptional regulators in the mouse immune system. Nat. Immunol. 14, 633– 643
47. Tusher, V. G., Tibshirani, R., and Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U.S.A. 98, 5116–5121
48. Cox, J., Hein, M. Y., Luber, C. A., Paron, I., Nagaraj, N., and Mann, M. (2014) MaxLFQ allows accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction. Mol. Cell. Proteomics 2513–2526
49. Nakashima, Y., et al. (1998) Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 18, 842–851
50. Zhao, C. F., and Herrington, D. M. (2016) The function of cathepsins B, D, and X in atherosclerosis. Am. J. Cardiovasc. Dis. 6, 163–170
51. Nachtigal, M., Ghaffar, A., and Mayer, E. P. (2008) Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice. Am. J. Pathol. 172, 247–255
52. Arai, S., Shelton, J. M., Chen, M., Bradley, M. N., Castrillo, A., Bookout, A. L., Mak, P. A., Edwards, P. A., Mangelsdorf, D. J., Tontonoz, P., and Miyazaki, T. (2005) A role for the apoptosis inhibitory factor AIM/Spalpha/ Api6 in atherosclerosis development. Cell Metab. 1, 201–213
53. Helgadottir, A., Manolescu, A., Thorleifsson, G., Gretarsdottir, S., Jonsdottir, H., Thorsteinsdottir, U., Samani, N. J., Gudmundsson, G., Grant, S. F., Thorgeirsson, G., Sveinbjornsdottir, S., Valdimarsson, E. M., Matthiasson, S. E., Johannsson, H., Gudmundsdottir, O., Gurney, M. E., Sainz, J., Thorhallsdottir, M., Andresdottir, M., Frigge, M. L., Topol, E. J., Kong, A., Gudnason, V., Hakonarson, H., Gulcher, J. R., and Stefansson, K. (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat. Genet. 36, 233–239
54. Esser, J., Rakonjac, M., Hofmann, B., Fischer, L., Provost, P., Schneider, G., Steinhilber, D., Samuelsson, B., and Radmark, O. (2010) Coactosin-like protein functions as a stabilizing chaperone for 5-lipoxygenase: role of tryptophan 102. Biochem. J. 425, 265–274
55. Poeter, M., Brandherm, I., Rossaint, J., Rosso, G., Shahin, V., Skryabin, B. V., Zarbock, A., Gerke, V., and Rescher, U. (2014) Annexin A8 controls leukocyte recruitment to activated endothelial cells via cell surface delivery of CD63. Nat. Commun. 5, 3738
56. Hutter, R., Huang, L., Speidl, W. S., Giannarelli, C., Trubin, P., Bauriedel, G., Klotman, M. E., Fuster, V., Badimon, J. J., and Klotman, P. E. (2013) Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma. Circulation 128, 2351–2363
57. Fu, M., Zhang, J., Tseng, Y. H., Cui, T., Zhu, X., Xiao, Y., Mou, Y., De Leon, H., Chang, M. M., Hamamori, Y., Kahn, C. R., and Chen, Y. E. (2005) Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration. Circulation 111, 1071–1077
58. Vesa, J., Hellsten, E., Verkruyse, L. A., Camp, L. A., Rapola, J., Santavuori, P., Hofmann, S. L., and Peltonen, L. (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376, 584–587
59. Ball, R. Y., Bindman, J. P., Carpenter, K. L., and Mitchinson, M. J. (1986) Oxidized low density lipoprotein induces ceroid accumulation by murine peritoneal macrophages in vitro. Atherosclerosis 60, 173–181
60. Demer, L. L., and Tintut, Y. (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117, 2938–2948
61. Van Campenhout, A., and Golledge, J. (2009) Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204, 321–329
62. Du, Y., Wang, Y., Wang, L., Liu, B., Tian, Q., Liu, C. J., Zhang, T., Xu, Q., Zhu, Y., Ake, O., Qi, Y., Tang, C., Kong, W., and Wang, X. (2011) Cartilage oligomeric matrix protein inhibits vascular smooth muscle calcification by interacting with bone morphogenetic protein-2. Circ. Res. 108, 917–928
63. Doherty, T. M., Asotra, K., Fitzpatrick, L. A., Qiao, J. H., Wilkin, D. J., Detrano, R. C., Dunstan, C. R., Shah, P. K., and Rajavashisth, T. B. (2003) Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc. Natl. Acad. Sci. U.S.A. 100, 11201–11206
64. Casagrande, V., Menghini, R., Menini, S., Marino, A., Marchetti, V., Cavalera, M., Fabrizi, M., Hribal, M. L., Pugliese, G., Gentileschi, P., Schillaci, O., Porzio, O., Lauro, D., Sbraccia, P., Lauro, R., and Federici, M. (2012) Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler. Thromb. Vasc. Biol. 32, 74 – 81
65. Stohr, R., Cavalera, M., Menini, S., Mavilio, M., Casagrande, V., Rossi, C., Urbani, A., Cardellini, M., Pugliese, G., Menghini, R., and Federici, M. (2014) Loss of TIMP3 exacerbates atherosclerosis in ApoE null mice. Atherosclerosis 235, 438–443
66. Manabe, R., Tsutsui, K., Yamada, T., Kimura, M., Nakano, I., Shimono, C., Sanzen, N., Furutani, Y., Fukuda, T., Oguri, Y., Shimamoto, K., Kiyozumi, D., Sato, Y., Sado, Y., Senoo, H., Yamashina, S., Fukuda, S., Kawai, J., Sugiura, N., Kimata, K., Hayashizaki, Y., and Sekiguchi, K. (2008) Tran-scriptome-based systematic identification of extracellular matrix proteins. Proc. Natl. Acad. Sci. U.S.A. 105, 12849–12854
67. Shao, J. S., Sierra, O. L., Cohen, R., Mecham, R. P., Kovacs, A., Wang, J., Distelhorst, K., Behrmann, A., Halstead, L. R., and Towler, D. A. (2011) Vascular calcification and aortic fibrosis: a bifunctional role for osteo-pontin in diabetic arteriosclerosis. Arterioscler. Thromb. Vasc. Biol. 31, 1821–1833
68. Izu, Y., Ezura, Y., Koch, M., Birk, D. E., and Noda, M. (2016) Collagens VI and XII form complexes mediating osteoblast interactions during osteogenesis. Cell Tissue Res. 364, 623–635
69. Lopes, J., Adiguzel, E., Gu, S., Liu, S. L., Hou, G., Heximer, S., Assoian, R. K., and Bendeck, M. P. (2013) Type VIII collagen mediates vessel wall remodeling after arterial injury and fibrous cap formation in atherosclerosis. Am. J. Pathol. 182, 2241–2253
70. Brandes, R. P. (2011) Vascular peroxidase 1/peroxidasin: a complex protein with a simple function? Cardiovasc Res. 91, 1–2
71. Bhave, G., Cummings, C. F., Vanacore, R. M., Kumagai-Cresse, C., Ero-Tolliver, I. A., Rafi, M., Kang, J. S., Pedchenko, V., Fessler, L. I., Fessler, J. H., and Hudson, B. G. (2012) Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis. Nat. Chem. Biol. 8, 784–790
72. Kohn, J. C., Lampi, M. C., and Reinhart-King, C. A. (2015) Age-related vascular stiffening: causes and consequences. Front. Genet. 6, 112
73. Silence, J., Lupu, F., Collen, D., and Lijnen, H. R. (2001) Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation. Arterioscler. Thromb. Vasc. Biol. 21, 1440–1445
74. Johnson, J. L., George, S. J., Newby, A. C., and Jackson, C. L. (2005) Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc. Natl. Acad. Sci. U.S.A. 102, 15575–15580
75. Traylor, M., Makela, K. M., Kilarski, L. L., Holliday, E. G., Devan, W. J., Nalls, M. A., Wiggins, K. L., Zhao, W., Cheng, Y. C., Achterberg, S., Malik, R., Sudlow, C., Bevan, S., Raitoharju, E., METASTROKE, International Stroke Genetics Consortium, Wellcome Trust Case Consortium 2 (WTCCC2), Oksala, N., Thijs, V., Lemmens, R., Lindgren, A., Slowik, A., Maguire, J. M., Walters, M., Algra, A., Sharma, P., Attia, J. R., Boncoraglio, G. B., Rothwell, P. M., de Bakker, P. I., Bis, J. C., Saleheen, D., Kittner, S. J., Mitchell, B. D., Rosand, J., Meschia, J. F., Levi, C., Dichgans, M., Lehtimaki, T., Lewis, C. M., and Markus, H. S. (2014) A novel MMP12 locus is associated with large artery atherosclerotic stroke using a genome-wide age-at-onset informed approach. PLoS Genet. 10, e1004469
76. Yu, G., Kovkarova-Naumovski, E., Jara, P., Parwani, A., Kass, D., Ruiz, V., Lopez-Otin, C., Rosas, I. O., Gibson, K. F., Cabrera, S., Ramirez, R., Yousem, S. A., Richards, T. J., Chensny, L. J., Selman, M., Kaminski, N., and Pardo, A. (2012) Matrix metalloproteinase-19 is a key regulator of lung fibrosis in mice and humans. Am. J. Respir. Crit. Care Med. 186, 752–762
77. Jonas, A., Thiem, S., Kuhlmann, T., Wagener, R., Aszodi, A., Nowell, C., Hagemeier, K., Laverick, L., Perreau, V., Jokubaitis, V., Emery, B., Kilpatrick, T., Butzkueven, H., and Gresle, M. (2014) Axonally derived matrilin-2 induces proinflammatory responses that exacerbate autoimmune neuroinflammation. J. Clin. Invest. 124, 5042–5056
78. Korpos, E., Deak, F., and Kiss, I. (2015) Matrilin-2, an extracellular adaptor protein, is needed for the regeneration of muscle, nerve and other tissues. Neural Regen. Res. 10, 866–869
79. Beckmann, G., and Bork, P. (1993) An adhesive domain detected in functionally diverse receptors. Trends Biochem. Sci. 18, 40–41
80. Alves, R. D., Eijken, M., van de Peppel, J., and van Leeuwen, J. P. (2014) Calcifying vascular smooth muscle cells and osteoblasts: independent cell types exhibiting extracellular matrix and biomineralization-related mimicries. BMC Genomics 15, 965
81. Chinetti-Gbaguidi, G., Daoudi, M., Rosa, M., Vinod, M., Louvet, L., Copin, C., Fanchon, M., Vanhoutte, J., Derudas, B., Belloy, L., Haulon, S., Zawadzki, C., Susen, S., Massy, Z. A., Eeckhoute, J., and Staels, B. (2017) Human alternative macrophages populate calcified areas of atherosclerotic lesions and display impaired RANKL-induced osteoclastic bone resorption activity. Circ. Res. 121, 19–30
82. Rogers, M. A., Aikawa, M., and Aikawa, E. (2017) Macrophage heterogeneity complicates reversal of calcification in cardiovascular tissues. Circ. Res. 121, 5–7
83. Qin, A., Cheng, T. S., Pavlos, N. J., Lin, Z., Dai, K. R., and Zheng, M. H. (2012) V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption. Int. J. Biochem. Cell Biol. 44, 1422–1435
84. Yuan, F. L., Li, X., Lu, W. G., Li, C. W., Li, J. P., and Wang, Y. (2010) The vacuolar ATPase in bone cells: a potential therapeutic target in osteoporosis. Mol. Biol. Rep. 37, 3561–3566
85. Hamerman, D. (2005) Osteoporosis and atherosclerosis: biological linkages and the emergence of dual-purpose therapies. QJM 98, 467– 484